JP2019531763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531763A5 JP2019531763A5 JP2019533313A JP2019533313A JP2019531763A5 JP 2019531763 A5 JP2019531763 A5 JP 2019531763A5 JP 2019533313 A JP2019533313 A JP 2019533313A JP 2019533313 A JP2019533313 A JP 2019533313A JP 2019531763 A5 JP2019531763 A5 JP 2019531763A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- sequence
- site
- anchor sequence
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023113050A JP7901054B2 (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
| JP2026070988A JP2026110713A (ja) | 2016-09-07 | 2026-04-22 | 遺伝子発現をモジュレートするための方法および組成物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662384603P | 2016-09-07 | 2016-09-07 | |
| US62/384,603 | 2016-09-07 | ||
| US201662416501P | 2016-11-02 | 2016-11-02 | |
| US62/416,501 | 2016-11-02 | ||
| US201662439327P | 2016-12-27 | 2016-12-27 | |
| US62/439,327 | 2016-12-27 | ||
| US201762542703P | 2017-08-08 | 2017-08-08 | |
| US62/542,703 | 2017-08-08 | ||
| PCT/US2017/050553 WO2018049073A1 (en) | 2016-09-07 | 2017-09-07 | Methods and compositions for modulating gene expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023113050A Division JP7901054B2 (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019531763A JP2019531763A (ja) | 2019-11-07 |
| JP2019531763A5 true JP2019531763A5 (cg-RX-API-DMAC7.html) | 2020-10-22 |
| JP7682604B2 JP7682604B2 (ja) | 2025-05-26 |
Family
ID=61562240
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533313A Active JP7682604B2 (ja) | 2016-09-07 | 2017-09-07 | 遺伝子発現をモジュレートするための方法および組成物 |
| JP2023113050A Active JP7901054B2 (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
| JP2026070988A Pending JP2026110713A (ja) | 2016-09-07 | 2026-04-22 | 遺伝子発現をモジュレートするための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023113050A Active JP7901054B2 (ja) | 2016-09-07 | 2023-07-10 | 遺伝子発現をモジュレートするための方法および組成物 |
| JP2026070988A Pending JP2026110713A (ja) | 2016-09-07 | 2026-04-22 | 遺伝子発現をモジュレートするための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US20190255106A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3510152A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7682604B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109890962A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017324550B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3035910A1 (cg-RX-API-DMAC7.html) |
| WO (4) | WO2018049075A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| WO2016073990A2 (en) | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
| CA2986310A1 (en) | 2015-05-11 | 2016-11-17 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
| US11911415B2 (en) | 2015-06-09 | 2024-02-27 | Editas Medicine, Inc. | CRISPR/Cas-related methods and compositions for improving transplantation |
| CA2999500A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2017165826A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| US11236313B2 (en) | 2016-04-13 | 2022-02-01 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| EP4650364A3 (en) | 2016-07-06 | 2026-01-21 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of pain related disorders |
| EP3481857B1 (en) | 2016-07-06 | 2026-02-11 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of pain related disorders |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
| MX2019002004A (es) | 2016-08-19 | 2019-10-09 | Whitehead Inst Biomedical Res | Metodos para editar la metilacion del adn. |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| WO2018049075A1 (en) | 2016-09-07 | 2018-03-15 | Flagship Pioneering, Inc. | Methods and compositions for modulating gene expression |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018111944A1 (en) | 2016-12-12 | 2018-06-21 | Whitehead Institute For Biomedical Research | Regulation of transcription through ctcf loop anchors |
| EP3555297A1 (en) | 2016-12-19 | 2019-10-23 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| WO2018129368A2 (en) | 2017-01-06 | 2018-07-12 | Editas Medicine, Inc. | Methods of assessing nuclease cleavage |
| US11873496B2 (en) | 2017-01-09 | 2024-01-16 | Whitehead Institute For Biomedical Research | Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops |
| EP3579858A4 (en) * | 2017-02-07 | 2020-12-23 | The Regents of The University of California | GENE THERAPY AGAINST HAPLOINSUFFICIENCY |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| CN117821509A (zh) | 2017-04-03 | 2024-04-05 | 编码治疗公司 | 组织选择性转基因表达 |
| US11499151B2 (en) | 2017-04-28 | 2022-11-15 | Editas Medicine, Inc. | Methods and systems for analyzing guide RNA molecules |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| CN110997908A (zh) | 2017-06-09 | 2020-04-10 | 爱迪塔斯医药公司 | 工程化的cas9核酸酶 |
| EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| CA3082251A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| CN118345115A (zh) | 2017-12-01 | 2024-07-16 | 编码治疗公司 | 工程化的dna结合蛋白 |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US12480140B2 (en) | 2018-05-06 | 2025-11-25 | Emendobio Inc. | Differential knockout of an allele of a heterozygous ELANE gene |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| AU2019291918B2 (en) | 2018-06-29 | 2025-06-12 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| JP7541508B2 (ja) | 2018-08-23 | 2024-08-28 | サンガモ セラピューティクス, インコーポレイテッド | 操作された標的特異的な塩基エディター |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| EP3867368A4 (en) * | 2018-10-15 | 2022-08-10 | Flagship Pioneering Innovations V, Inc. | DESTROYING THE ASSEMBLY OF A GENOMIC COMPLEX IN FUSION GENES |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| WO2020113135A1 (en) * | 2018-11-29 | 2020-06-04 | Flagship Pioneering Innovations V, Inc. | Methods of modulating rna |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020176553A1 (en) * | 2019-02-25 | 2020-09-03 | Sense Therapeutics Inc. | Intracellular mutation targeting therapy |
| CN113710693B (zh) | 2019-02-25 | 2025-07-15 | 马萨诸塞大学 | Dna结合结构域反式激活因子及其用途 |
| CN113906142A (zh) * | 2019-03-18 | 2022-01-07 | 桑德农业公司 | 植物中基因表达的可编程表观遗传控制 |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| SG11202113048SA (en) * | 2019-05-29 | 2021-12-30 | Encoded Therapeutics Inc | Compositions and methods for selective gene regulation |
| EP4034658A4 (en) * | 2019-09-23 | 2023-11-29 | Flagship Pioneering Innovations V, Inc. | MODULATION OF GENOMIC COMPLEXES |
| CN114729376A (zh) | 2019-09-23 | 2022-07-08 | 欧米茄治疗公司 | 用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法 |
| US20220267756A1 (en) * | 2019-09-23 | 2022-08-25 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulating genomic complex integrity index |
| AU2020355000A1 (en) | 2019-09-23 | 2022-03-17 | Sepia Therapeutics, Inc. | Compositions and methods for modulating apolipoprotein B (APOB) gene expression |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US12258599B2 (en) | 2019-11-06 | 2025-03-25 | Emendobio Inc. | Method to inactivate a mutant allele of an ELANE gene |
| US12435334B2 (en) | 2019-11-06 | 2025-10-07 | Emendobio Inc. | Differential knockout of an allele of a heterozygous ELANE gene-II |
| WO2021092227A1 (en) * | 2019-11-06 | 2021-05-14 | Emendobio Inc. | Differential knockout of an allele of a heterozygous elane gene using guides 21-30 nucleotides in length |
| CN114729403A (zh) * | 2019-11-22 | 2022-07-08 | 新加坡国立大学 | 用于鉴定和验证共有候选抗原和共有抗原特异性t淋巴细胞对的方法和系统 |
| CA3162809A1 (en) * | 2020-01-17 | 2021-07-22 | Nzumbe, Inc. | Induction of dna strand breaks at chromatin targets |
| US20220112509A1 (en) * | 2020-02-26 | 2022-04-14 | Imra Japan Kabushikikaisha | Gene knock-in method, gene knock-in cell fabrication method, gene knock-in cell, malignant transformation risk evaluation method, cancer cell production method, and kit for use in these |
| BR112022017715A2 (pt) | 2020-03-04 | 2022-11-16 | Flagship Pioneering Innovations Vi Llc | Métodos e composições para modular um genoma |
| WO2021183720A1 (en) | 2020-03-11 | 2021-09-16 | Omega Therapeutics, Inc. | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression |
| US20230201269A1 (en) * | 2020-04-24 | 2023-06-29 | Spinalcyte, Llc | Treatment of frontotemporal dementia using fibroblasts and products thereof |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| WO2022072546A2 (en) * | 2020-09-29 | 2022-04-07 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting the expression of multiple genes |
| CN116635086A (zh) * | 2020-09-29 | 2023-08-22 | 旗舰先锋创新V股份有限公司 | 用于抑制多个基因的表达的组合物和方法 |
| CN112301020B (zh) * | 2020-10-19 | 2024-04-12 | 复旦大学附属肿瘤医院 | Iii类脱氧核酶突变体及其制备方法与应用 |
| CN114621959B (zh) * | 2020-12-08 | 2023-05-26 | 中国科学院海洋研究所 | 一种编码牙鲆igf2可溶性蛋白的基因及蛋白重组表达方法与应用 |
| AU2021409729A1 (en) * | 2020-12-22 | 2023-07-13 | Nchroma Bio, Inc. | Compositions and methods for epigenetic editing |
| EP4308153A4 (en) * | 2021-03-16 | 2025-12-17 | Massachusetts Gen Hospital | Compositions and methods for treating diseases associated with nucleoside repeat expansion |
| WO2023283359A2 (en) | 2021-07-07 | 2023-01-12 | Omega Therapeutics, Inc. | Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression |
| US12636303B2 (en) * | 2021-08-30 | 2026-05-26 | Sachi Bioworks Inc. | Composition of a therapeutic oligomer |
| KR20260037664A (ko) | 2021-09-08 | 2026-03-18 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈을 조절하기 위한 방법 및 조성물 |
| IL311610A (en) | 2021-09-21 | 2024-05-01 | Scribe Therapeutics Inc | Engineered CASX suppressor systems |
| WO2023225349A2 (en) * | 2022-05-20 | 2023-11-23 | Helex Inc. | Tissue specific methods and compositions for gene editing |
| US20250375464A1 (en) * | 2022-06-22 | 2025-12-11 | Flagship Pioneering Innovations V, Inc. | Formulations for modulating myc expression |
| CA3258422A1 (en) * | 2022-06-22 | 2023-12-28 | Flagship Pioneering Innovations V, Inc. | POLYTHERAPIES INCLUDING MYC MODULATION |
| JP2026523341A (ja) | 2023-05-15 | 2026-07-14 | エヌクロマ・バイオ,インコーポレーテッド | Hbv遺伝子発現のエピジェネティック調節のための組成物および方法 |
| JP2026518711A (ja) | 2023-05-16 | 2026-06-09 | フラッグシップ ラブズ 114, インコーポレイテッド | 標的遺伝子のメチル化を調節するための方法及び組成物 |
| WO2024238723A1 (en) | 2023-05-16 | 2024-11-21 | Omega Therapeutics, Inc. | Methods and compositions for modulating pcsk9 expression |
| EP4716741A2 (en) | 2023-05-23 | 2026-04-01 | Flagship Labs 114, Inc. | Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression |
| WO2025019742A1 (en) | 2023-07-19 | 2025-01-23 | Omega Therapeutics, Inc. | Methods and compositions for modulating ctnnb1 expression |
| WO2025085423A1 (en) * | 2023-10-19 | 2025-04-24 | The Broad Institute, Inc. | Method of multi-locus crispri targeting with a single truncated guide |
| CN118773200B (zh) * | 2024-07-18 | 2025-06-10 | 华中科技大学同济医学院附属同济医院 | 一种ttc21b基因突变位点及其应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622569B1 (en) | 2003-04-24 | 2015-12-02 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metallproteases |
| WO2009146033A2 (en) | 2008-03-31 | 2009-12-03 | Sma Foundation | Compositions and methods for modulating smn activity |
| KR20110110776A (ko) | 2008-12-18 | 2011-10-07 | 다이서나 파마수이티컬, 인크. | 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법 |
| EP2414524B1 (en) | 2009-04-03 | 2017-08-23 | Centre National De La Recherche Scientifique | Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2694686B2 (en) * | 2011-04-06 | 2023-07-19 | The University of Chicago | COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC) |
| US9234213B2 (en) * | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| CN105408483A (zh) * | 2013-03-15 | 2016-03-16 | 通用医疗公司 | 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向 |
| WO2014172470A2 (en) | 2013-04-16 | 2014-10-23 | Whitehead Institute For Biomedical Research | Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal |
| KR20160048212A (ko) | 2013-09-04 | 2016-05-03 | 씨에스아이알 | 유전자 발현을 침묵화시키기 위해 유전자 조절 인자들을 표적으로하는 부위-특이적인 뉴클레아제 단일 세포 분석법 |
| US9526784B2 (en) * | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| WO2015038892A1 (en) | 2013-09-13 | 2015-03-19 | Moderna Therapeutics, Inc. | Polynucleotide compositions containing amino acids |
| US20150376612A1 (en) * | 2014-06-10 | 2015-12-31 | The General Hospital Corporation | CCCTC-Binding Factor (CTCF) RNA Interactome |
| US10286086B2 (en) | 2014-06-19 | 2019-05-14 | Modernatx, Inc. | Alternative nucleic acid molecules and uses thereof |
| WO2016014794A1 (en) * | 2014-07-25 | 2016-01-28 | Sangamo Biosciences, Inc. | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells |
| AU2015298571B2 (en) * | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| GB201418965D0 (cg-RX-API-DMAC7.html) | 2014-10-24 | 2014-12-10 | Ospedale San Raffaele And Fond Telethon | |
| TWI716367B (zh) * | 2014-10-31 | 2021-01-21 | 麻省理工學院 | 用於常間回文重複序列叢集(crispr)之大量平行組合性基因學 |
| WO2016073990A2 (en) * | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
| WO2016081798A1 (en) * | 2014-11-20 | 2016-05-26 | Children's Medical Center Corporation | Methods relating to the detection of recurrent and non-specific double strand breaks in the genome |
| WO2016089920A1 (en) | 2014-12-01 | 2016-06-09 | The Broad Institute, Inc. | Method for in situ determination of nucleic acid proximity |
| WO2016103233A2 (en) | 2014-12-24 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Systems and methods for genome modification and regulation |
| WO2016115326A1 (en) * | 2015-01-15 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for modulating genome editing |
| US10023922B2 (en) | 2015-03-23 | 2018-07-17 | Whitehead Institute For Biomedical Research | Reporter of genomic methylation and uses thereof |
| CN107787367B (zh) | 2015-04-06 | 2021-10-26 | 里兰斯坦福初级大学理事会 | 用于crispr/cas介导的基因调控的化学修饰的引导rna |
| EP3087974A1 (en) * | 2015-04-29 | 2016-11-02 | Rodos BioTarget GmbH | Targeted nanocarriers for targeted drug delivery of gene therapeutics |
| US20170014449A1 (en) * | 2015-07-13 | 2017-01-19 | Elwha LLC, a limited liability company of the State of Delaware | Site-specific epigenetic editing |
| WO2017011710A2 (en) | 2015-07-14 | 2017-01-19 | Whitehead Institute For Biomedical Research | Chromosome neighborhood structures and methods relating thereto |
| AU2016308339A1 (en) * | 2015-08-18 | 2018-04-12 | Baylor College Of Medicine | Methods and compositions for altering function and structure of chromatin loops and/or domains |
| EP3344766B8 (en) | 2015-09-01 | 2021-03-17 | Dana-Farber Cancer Institute, Inc. | Systems and methods for selection of grna targeting strands for cas9 localization |
| WO2017064546A1 (en) * | 2015-09-24 | 2017-04-20 | Crispr Therapeutics Ag | Novel family of rna-programmable endonucleases and their uses in genome editing and other applications |
| US20170130247A1 (en) | 2015-09-30 | 2017-05-11 | Whitehead Institute For Biomedical Research | Compositions and methods for altering gene expression |
| WO2017075406A1 (en) | 2015-10-29 | 2017-05-04 | Whitehead Institute For Biomedical Research | Transcription factor trapping by rna in gene regulatory elements |
| US11339442B2 (en) | 2015-12-14 | 2022-05-24 | The General Hospital Corporation | Methods of detecting insulator dysfunction and oncogene activation for screening, diagnosis and treatment of patients in need thereof |
| JP2019508037A (ja) * | 2016-02-16 | 2019-03-28 | イェール ユニバーシティーYale Universit | 標的化遺伝子編集を増強するための組成物およびその使用方法 |
| GB201608000D0 (en) | 2016-05-06 | 2016-06-22 | Oxford Biodynamics Ltd | Chromosome detection |
| MX2019002004A (es) * | 2016-08-19 | 2019-10-09 | Whitehead Inst Biomedical Res | Metodos para editar la metilacion del adn. |
| WO2018049075A1 (en) | 2016-09-07 | 2018-03-15 | Flagship Pioneering, Inc. | Methods and compositions for modulating gene expression |
| WO2018085460A2 (en) | 2016-11-02 | 2018-05-11 | Flagship Pioneering, Inc. | Compositions and methods for cell delivery |
| WO2018111944A1 (en) | 2016-12-12 | 2018-06-21 | Whitehead Institute For Biomedical Research | Regulation of transcription through ctcf loop anchors |
| US11873496B2 (en) | 2017-01-09 | 2024-01-16 | Whitehead Institute For Biomedical Research | Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops |
| WO2018160908A1 (en) | 2017-03-03 | 2018-09-07 | Flagship Pioneering, Inc. | Methods and systems for modifying dna |
| US20210254056A1 (en) | 2017-05-05 | 2021-08-19 | Camp4 Therapeutics Corporation | Identification and targeted modulation of gene signaling networks |
| US20200208128A1 (en) | 2017-08-14 | 2020-07-02 | Camp4 Therapeutics Corporation | Methods of treating liver diseases |
| WO2019071054A1 (en) | 2017-10-04 | 2019-04-11 | The Broad Institute, Inc. | METHODS AND COMPOSITIONS FOR MODIFYING THE FUNCTION AND STRUCTURE OF BUCKLES AND / OR CHROMATIN DOMAINS |
| EP3587516B1 (en) | 2018-06-27 | 2024-05-22 | Ricoh Company, Ltd. | Ink, method of manufacturing acrylic resin particle, printing method, ink accommodating unit, and inkjet printing device |
| EP3867368A4 (en) | 2018-10-15 | 2022-08-10 | Flagship Pioneering Innovations V, Inc. | DESTROYING THE ASSEMBLY OF A GENOMIC COMPLEX IN FUSION GENES |
| WO2020113135A1 (en) | 2018-11-29 | 2020-06-04 | Flagship Pioneering Innovations V, Inc. | Methods of modulating rna |
| JP2022548800A (ja) | 2019-09-23 | 2022-11-21 | オメガ セラピューティクス, インコーポレイテッド | フラタキシン発現を調節し、フリードライヒ運動失調症を治療するための方法及び組成物 |
| US20220267756A1 (en) | 2019-09-23 | 2022-08-25 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulating genomic complex integrity index |
| EP4034658A4 (en) | 2019-09-23 | 2023-11-29 | Flagship Pioneering Innovations V, Inc. | MODULATION OF GENOMIC COMPLEXES |
| WO2022067033A1 (en) | 2020-09-24 | 2022-03-31 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting gene expression |
| WO2022072546A2 (en) | 2020-09-29 | 2022-04-07 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for inhibiting the expression of multiple genes |
| WO2022132195A2 (en) | 2020-12-15 | 2022-06-23 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for modulation myc expression |
-
2017
- 2017-09-07 WO PCT/US2017/050556 patent/WO2018049075A1/en not_active Ceased
- 2017-09-07 WO PCT/US2017/050558 patent/WO2018049077A1/en not_active Ceased
- 2017-09-07 CA CA3035910A patent/CA3035910A1/en active Pending
- 2017-09-07 US US16/330,999 patent/US20190255106A1/en not_active Abandoned
- 2017-09-07 CN CN201780066156.1A patent/CN109890962A/zh active Pending
- 2017-09-07 AU AU2017324550A patent/AU2017324550B2/en active Active
- 2017-09-07 JP JP2019533313A patent/JP7682604B2/ja active Active
- 2017-09-07 EP EP17849560.2A patent/EP3510152A4/en active Pending
- 2017-09-07 WO PCT/US2017/050561 patent/WO2018049079A1/en not_active Ceased
- 2017-09-07 WO PCT/US2017/050553 patent/WO2018049073A1/en not_active Ceased
- 2017-11-22 US US15/821,632 patent/US11312955B2/en active Active
-
2018
- 2018-10-09 US US16/155,688 patent/US11624065B2/en active Active
-
2022
- 2022-03-18 US US17/698,912 patent/US12509683B2/en active Active
- 2022-03-18 US US17/698,917 patent/US12522823B2/en active Active
-
2023
- 2023-07-10 JP JP2023113050A patent/JP7901054B2/ja active Active
-
2024
- 2024-06-11 AU AU2024203956A patent/AU2024203956A1/en active Pending
-
2025
- 2025-12-10 US US19/414,635 patent/US20260226464A1/en active Pending
-
2026
- 2026-04-22 JP JP2026070988A patent/JP2026110713A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI880645B (zh) | 抑制lpa之基因表現之組合物及方法 | |
| US11136597B2 (en) | Compositions for enhancing targeted gene editing and methods of use thereof | |
| US20210322577A1 (en) | Methods and systems for modifying dna | |
| JP2016513976A5 (cg-RX-API-DMAC7.html) | ||
| US20200308590A1 (en) | Compositions and methods for treatment of cystic fibrosis | |
| TW201920227A (zh) | 用於抑制脂蛋白元C-III (APOC3)表現之RNAi試劑及組合物 | |
| US20180312839A1 (en) | Methods and compositions for increasing smn expression | |
| CA3035910A1 (en) | Methods and compositions for modulating gene expression | |
| WO2018187493A1 (en) | Compositions and methods for in utero delivery | |
| EP3573618B1 (en) | Compositions and methods for hemoglobin production | |
| JP2010515707A5 (cg-RX-API-DMAC7.html) | ||
| CN104769112A (zh) | 用于在细胞中表达蛋白质的方法和产品 | |
| EP4041894A1 (en) | COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4a) GENE EXPRESSION | |
| ES2291536T3 (es) | Control de la expresion de gen usando un complejo de un oligonucleotido y un peptido regulatorio. | |
| CN112912497A (zh) | 工程化长散在元件(line)转座子及其使用方法 | |
| AU2021234302A1 (en) | Compositions and methods for modulating forkhead box p3 (foxp3) gene expression | |
| CA3097914A1 (en) | Methods of gene therapy | |
| US20240279687A1 (en) | Peptide nucleic acids for spatiotemporal control of crispr-cas binding | |
| JP2020521491A5 (cg-RX-API-DMAC7.html) | ||
| JP2024530169A (ja) | 方法 | |
| US20220243211A1 (en) | Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof | |
| US20220372474A1 (en) | Hydroxymethyl-modified gamma-pna compositions and methods of use thereof | |
| CN115317610A (zh) | 基于vps9d1-as1靶点的aso药物在肿瘤治疗中的应用 | |
| WO2022250072A1 (ja) | 心疾患治療薬 | |
| WO2020112195A1 (en) | Compositions, technologies and methods of using plerixafor to enhance gene editing |